Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX +9.72%21 3-Year EPS without NRI Growth Rate is 65.60% as of Dec. 2025, which is at its 10-year median of 65.60. GuruFocus rates ASX:CSX with a GF Score™ of 21/100 and a GF Value™ of A$0.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 655 Medical Devices & Instruments companies, CleanSpace Holdings ranks better than 93.28% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 65.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of CleanSpace Holdings was 65.60% per year. The lowest was 65.60% per year. And the median was 65.60% per year.
CleanSpace Holdings (ASX:CSX) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
CleanSpace Holdings 3-Year EPS without NRI Growth Rate Related Terms
ASX:CSX vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, CleanSpace Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's 3-Year EPS without NRI Growth Rate falls into.
CleanSpace Holdings 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 65.60% mean?
CleanSpace Holdings (ASX:CSX) has a 3-Year EPS without NRI Growth Rate of 65.60% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for CleanSpace Holdings and its competitors. This is near median its historical median of 65.60. Over the past decade, CleanSpace Holdings' 3-Year EPS without NRI Growth Rate has ranged from 65.60 to 65.60. According to the industry distribution chart, CleanSpace Holdings ranks #44 out of 655 companies in the Medical Devices & Instruments industry, placing it in the top 6.7%.
Is CleanSpace Holdings' 3-Year EPS without NRI Growth Rate too high?
CleanSpace Holdings' current 3-Year EPS without NRI Growth Rate of 65.60% is near median its 10-year median of 65.60. Over the past 10 years, this metric has ranged from a low of 65.60 to a high of 65.60. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 8.10. CleanSpace Holdings' value of 65.60% is 709.9% above this industry median. Based on the distribution chart, CleanSpace Holdings ranks #44 out of 655 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, CleanSpace Holdings has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #44 out of 655 companies for 3-Year EPS without NRI Growth Rate. This places CleanSpace Holdings in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 8.10. CleanSpace Holdings' value of 65.60% is 709.9% above this benchmark. Historically, CleanSpace Holdings' own 3-Year EPS without NRI Growth Rate has ranged from 65.60 to 65.60 over the past decade. While the company's 10-year median is 65.60 vs. the industry median of 8.10, CleanSpace Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.10, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current 3-Year EPS without NRI Growth Rate of 65.60% is 709.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for CleanSpace Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current 3-Year EPS without NRI Growth Rate is 65.60%, which is near median its own 10-year median of 65.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.56, compared to a current price of A$0.40 — trading 29.5% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 65.60%, which is near median its 10-year median of 65.60 and 709.9% above the Medical Devices & Instruments industry median of 8.10. CleanSpace Holdings' overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current 3-Year EPS without NRI Growth Rate is 65.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 29.5% below its estimated GF Value™ of A$0.56.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
3-Year EPS without NRI Growth Rate: 65.60% (near median its 10-year median of 65.60)
GF Value™: A$0.56 vs. price of A$0.40 (29.5% below fair value)
Industry Position: 709.9% above the Medical Devices & Instruments median (#44 of 655)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
21GF Score
Get the complete analysis for ASX:CSX
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
